A survey has found six in 10 over-65s are already worrying about catching the flu or COVID-19 when visiting A&E this winter.

AI in the NHS App will direct patients to GPs, pharmacies, or A&E, reaching 200,000 people in year one. Health leaders question the evidence base.

The NHS has told people that an affordable product could help prevent irritating symptoms that millions of hay fever sufferers will experience during the 'red alert' weekend. People may find some ...

The British Medical Association has passed a motion calling for an investigation into the use of the IHRA antisemitism definition in the NHS, citing concerns over free expression among staff. The ...

Without investment in more radiographers, NHS waiting lists will continue to rise inexorably, says CEO of the Society and College of Radiographers, Richard Evans In your article (Record number of ...

A therapy that can delay the onset of type 1 diabetes (T1D) by an average of nearly 3 years has been recommended for NHS use in England — the first country in Europe to do so through a health ...

In a landmark decision for people with early type 1 diabetes (T1D) in the UK, Sanofi's first-of-its-kind therapy Tzield, which can delay progression of the disease, has been given a green light for ...

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every day ...

A first-of-its-kind treatment that can delay the onset of type 1 diabetes has been recommended for use on the NHS. Teplizumab, which can slow the onset of the condition for up to three years, has been ...

Britain's National Health Service will make its pioneering Jewish BRCA testing program permanent after a pilot initiative identified hundreds of people carrying inherited cancer-linked genetic ...

The use of point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) in nursing homes did not affect the ...